Determination of Non Alcoholic Fatty Liver Disease in Metabolic Syndrome Patients
DOI:
https://doi.org/10.9734/bpi/caprd/v9/2472CKeywords:
Metabolic syndrome, diabetes mellitus, cirrhosis, and hypertensionAbstract
The study's goal is to determine the association of nonalcoholic fatty liver disease in metabolic syndrome patients in order to determine the prevalence of nonalcoholic fatty liver disease in metabolic syndrome patients who have already been diagnosed in the South Indian population. Discover the relationship and general characteristics of nonalcoholic fatty liver disease in metabolic syndrome patients. To identify possible risk factors for steatohepatitis in patients with nonalcoholic fatty liver disease and metabolic syndrome, as well as risk categories for steatohepatitis in these patients. In nonalcoholic fatty liver cases, there is a rising incidence of all metabolic syndrome components, as well as alterations in biochemical markers.
Published
2022-02-23
How to Cite
Pinky Karam, B. Shanthi, & Mary Chandrika. (2022). Determination of Non Alcoholic Fatty Liver Disease in Metabolic Syndrome Patients. Current Aspects in Pharmaceutical Research and Development Vol. 9, 56–69. https://doi.org/10.9734/bpi/caprd/v9/2472C
Issue
Section
Chapters